Infectious Disease Molecular Diagnostics Market Size, Share, Trends, Growth Outlook

Infectious Disease Molecular Diagnostics Market is estimated to increase at a growth rate of 3.4% CAGR over the forecast period from 2024 to 2030.

 

The Infectious Disease Molecular Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product & Service (Reagents, Kits, Consumables, Instruments, Software & Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample Type (Blood, Serum, and Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others).

 

An Introduction to Infectious Disease Molecular Diagnostics Market in 2024

The infectious disease molecular diagnostics market in 2024 focuses on molecular testing methods and technologies used for the detection, characterization, and monitoring of infectious agents at the genetic level. Molecular diagnostics play a crucial role in identifying pathogens, determining their virulence factors, and guiding targeted therapy decisions based on genetic markers of antimicrobial resistance or strain typing. Key applications include polymerase chain reaction (PCR), nucleic acid sequencing, and microarray-based assays for the rapid and sensitive detection of viral, bacterial, and fungal pathogens in clinical specimens such as blood, respiratory secretions, and tissue samples. Market dynamics are driven by factors such as the increasing demand for precision medicine, rising incidence of antimicrobial resistance, and advancements in genomics and bioinformatics. Collaboration between diagnostic companies, academic research institutions, and healthcare providers fuels innovation in infectious disease molecular diagnostics, leading to the development of multiplex assays, point-of-care devices, and digital PCR platforms that improve diagnostic accuracy, turnaround times, and patient outcomes in the management of infectious diseases.

 

Infectious Disease Molecular Diagnostics Market Trend: Adoption of Next-Generation Sequencing (NGS) in Infectious Disease Molecular Diagnostics

A prominent trend in the Infectious Disease Molecular Diagnostics market is the increasing adoption of next-generation sequencing (NGS) technologies. NGS enables comprehensive genomic analysis of infectious pathogens, offering high throughput, sensitivity, and accuracy in identifying and characterizing microbial strains. With the ability to sequence entire genomes or specific gene targets rapidly, NGS platforms facilitate the detection of emerging infectious diseases, surveillance of antimicrobial resistance, and investigation of disease outbreaks. Moreover, NGS-based molecular diagnostics empower precision medicine approaches by guiding personalized treatment strategies based on the genetic profile of pathogens and host factors, driving the market growth for advanced molecular diagnostic solutions in infectious disease management.

Infectious Disease Molecular Diagnostics Market Driver: Growing Global Burden of Infectious Diseases

A key driver in the Infectious Disease Molecular Diagnostics market is the growing global burden of infectious diseases. Infectious pathogens, including bacteria, viruses, fungi, and parasites, continue to pose significant public health challenges worldwide, leading to morbidity, mortality, and economic burden. Factors such as population growth, urbanization, international travel, antimicrobial resistance, and climate change contribute to the emergence and spread of infectious diseases, necessitating robust diagnostic tools for timely and accurate detection. Molecular diagnostic tests offer rapid and sensitive detection of pathogens, enabling early intervention, outbreak control, and surveillance efforts. As healthcare systems prioritize infectious disease management, there is increasing demand for molecular diagnostics to support effective patient care and public health interventions, thereby propelling market growth.

Infectious Disease Molecular Diagnostics Market Opportunity: Expansion of Point-of-Care Molecular Testing

An opportunity for market expansion in the Infectious Disease Molecular Diagnostics market lies in the expansion of point-of-care (POC) molecular testing. POC molecular testing offers rapid and on-site detection of infectious pathogens, allowing healthcare providers to make timely clinical decisions at the patient's bedside or in resource-limited settings. With advancements in molecular diagnostic technologies, such as isothermal amplification and miniaturized instruments, POC molecular tests are becoming more accessible, user-friendly, and cost-effective. By leveraging POC molecular testing platforms, healthcare facilities can improve patient management, infection control, and antimicrobial stewardship, particularly in settings where centralized laboratory infrastructure is limited or inaccessible. Investing in the development and commercialization of POC molecular testing solutions presents an opportunity for diagnostic companies to address unmet needs and expand their market presence in infectious disease diagnostics.

 

Infectious Disease Molecular Diagnostics Market Segmentation

By Product & Service

Reagents

Kits

Consumables

Instruments

Software & Services

 

By Type of Testing

Laboratory Testing

PoC Testing

 

By Technology

Immunodiagnostics

Polymerase Chain Reaction

Clinical Microbiology

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-generation Sequencing

DNA Microarray

Others

 

By Disease Type

Hepatitis

-Hepatitis B

-Hepatitis C

-Others

HIV

Hospital-acquired Infections

Mosquito-borne Diseases

HPV

Chlamydia trachomatis

Neisseria gonorrhea

Tuberculosis

Influenza

Syphilis

Others

 

By Sample Type

Blood, Serum, and Plasma

Urine

Others

 

By End-User

Diagnostic Laboratories

Hospitals & Clinics

Academic Research Institutes

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Infectious Disease Molecular Diagnostics Market Companies

Abbott

bioMérieux

Danaher

F. Hoffmann-La Roche Ltd

Siemens Healthineers AG

*- List Not Exhaustive

 

Reasons to Buy the Infectious Disease Molecular Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Infectious Disease Molecular Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Infectious Disease Molecular Diagnostics Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Infectious Disease Molecular Diagnostics Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Infectious Disease Molecular Diagnostics Market Size Outlook, $ Million, 2021 to 2030

3.2 Infectious Disease Molecular Diagnostics Market Outlook by Type, $ Million, 2021 to 2030

3.3 Infectious Disease Molecular Diagnostics Market Outlook by Product, $ Million, 2021 to 2030

3.4 Infectious Disease Molecular Diagnostics Market Outlook by Application, $ Million, 2021 to 2030

3.5 Infectious Disease Molecular Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Infectious Disease Molecular Diagnostics Market Industry

4.2 Key Market Trends in Infectious Disease Molecular Diagnostics Market Industry

4.3 Potential Opportunities in Infectious Disease Molecular Diagnostics Market Industry

4.4 Key Challenges in Infectious Disease Molecular Diagnostics Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Infectious Disease Molecular Diagnostics Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Infectious Disease Molecular Diagnostics Market Outlook By Segments

7.1 Infectious Disease Molecular Diagnostics Market Outlook by Segments

By Product & Service

Reagents

Kits

Consumables

Instruments

Software & Services

By Type of Testing

Laboratory Testing

PoC Testing

By Technology

Immunodiagnostics

Polymerase Chain Reaction

Clinical Microbiology

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-generation Sequencing

DNA Microarray

Others

By Disease Type

Hepatitis

-Hepatitis B

-Hepatitis C

-Others

HIV

Hospital-acquired Infections

Mosquito-borne Diseases

HPV

Chlamydia trachomatis

Neisseria gonorrhea

Tuberculosis

Influenza

Syphilis

Others

By Sample Type

Blood, Serum, and Plasma

Urine

Others

By End-User

Diagnostic Laboratories

Hospitals & Clinics

Academic Research Institutes

Others

 

8 North America Infectious Disease Molecular Diagnostics Market Analysis And Outlook To 2030

8.1 Introduction to North America Infectious Disease Molecular Diagnostics Markets in 2024

8.2 North America Infectious Disease Molecular Diagnostics Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Infectious Disease Molecular Diagnostics Market size Outlook by Segments, 2021-2030

By Product & Service

Reagents

Kits

Consumables

Instruments

Software & Services

By Type of Testing

Laboratory Testing

PoC Testing

By Technology

Immunodiagnostics

Polymerase Chain Reaction

Clinical Microbiology

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-generation Sequencing

DNA Microarray

Others

By Disease Type

Hepatitis

-Hepatitis B

-Hepatitis C

-Others

HIV

Hospital-acquired Infections

Mosquito-borne Diseases

HPV

Chlamydia trachomatis

Neisseria gonorrhea

Tuberculosis

Influenza

Syphilis

Others

By Sample Type

Blood, Serum, and Plasma

Urine

Others

By End-User

Diagnostic Laboratories

Hospitals & Clinics

Academic Research Institutes

Others

 

9 Europe Infectious Disease Molecular Diagnostics Market Analysis And Outlook To 2030

9.1 Introduction to Europe Infectious Disease Molecular Diagnostics Markets in 2024

9.2 Europe Infectious Disease Molecular Diagnostics Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Infectious Disease Molecular Diagnostics Market Size Outlook By Segments, 2021-2030

By Product & Service

Reagents

Kits

Consumables

Instruments

Software & Services

By Type of Testing

Laboratory Testing

PoC Testing

By Technology

Immunodiagnostics

Polymerase Chain Reaction

Clinical Microbiology

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-generation Sequencing

DNA Microarray

Others

By Disease Type

Hepatitis

-Hepatitis B

-Hepatitis C

-Others

HIV

Hospital-acquired Infections

Mosquito-borne Diseases

HPV

Chlamydia trachomatis

Neisseria gonorrhea

Tuberculosis

Influenza

Syphilis

Others

By Sample Type

Blood, Serum, and Plasma

Urine

Others

By End-User

Diagnostic Laboratories

Hospitals & Clinics

Academic Research Institutes

Others

 

10 Asia Pacific Infectious Disease Molecular Diagnostics Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Infectious Disease Molecular Diagnostics Markets in 2024

10.2 Asia Pacific Infectious Disease Molecular Diagnostics Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Infectious Disease Molecular Diagnostics Market size Outlook by Segments, 2021-2030

By Product & Service

Reagents

Kits

Consumables

Instruments

Software & Services

By Type of Testing

Laboratory Testing

PoC Testing

By Technology

Immunodiagnostics

Polymerase Chain Reaction

Clinical Microbiology

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-generation Sequencing

DNA Microarray

Others

By Disease Type

Hepatitis

-Hepatitis B

-Hepatitis C

-Others

HIV

Hospital-acquired Infections

Mosquito-borne Diseases

HPV

Chlamydia trachomatis

Neisseria gonorrhea

Tuberculosis

Influenza

Syphilis

Others

By Sample Type

Blood, Serum, and Plasma

Urine

Others

By End-User

Diagnostic Laboratories

Hospitals & Clinics

Academic Research Institutes

Others

 

11 South America Infectious Disease Molecular Diagnostics Market Analysis And Outlook To 2030

11.1 Introduction to South America Infectious Disease Molecular Diagnostics Markets in 2024

11.2 South America Infectious Disease Molecular Diagnostics Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Infectious Disease Molecular Diagnostics Market size Outlook by Segments, 2021-2030

By Product & Service

Reagents

Kits

Consumables

Instruments

Software & Services

By Type of Testing

Laboratory Testing

PoC Testing

By Technology

Immunodiagnostics

Polymerase Chain Reaction

Clinical Microbiology

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-generation Sequencing

DNA Microarray

Others

By Disease Type

Hepatitis

-Hepatitis B

-Hepatitis C

-Others

HIV

Hospital-acquired Infections

Mosquito-borne Diseases

HPV

Chlamydia trachomatis

Neisseria gonorrhea

Tuberculosis

Influenza

Syphilis

Others

By Sample Type

Blood, Serum, and Plasma

Urine

Others

By End-User

Diagnostic Laboratories

Hospitals & Clinics

Academic Research Institutes

Others

 

12 Middle East And Africa Infectious Disease Molecular Diagnostics Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Infectious Disease Molecular Diagnostics Markets in 2024

12.2 Middle East and Africa Infectious Disease Molecular Diagnostics Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Infectious Disease Molecular Diagnostics Market size Outlook by Segments, 2021-2030

By Product & Service

Reagents

Kits

Consumables

Instruments

Software & Services

By Type of Testing

Laboratory Testing

PoC Testing

By Technology

Immunodiagnostics

Polymerase Chain Reaction

Clinical Microbiology

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-generation Sequencing

DNA Microarray

Others

By Disease Type

Hepatitis

-Hepatitis B

-Hepatitis C

-Others

HIV

Hospital-acquired Infections

Mosquito-borne Diseases

HPV

Chlamydia trachomatis

Neisseria gonorrhea

Tuberculosis

Influenza

Syphilis

Others

By Sample Type

Blood, Serum, and Plasma

Urine

Others

By End-User

Diagnostic Laboratories

Hospitals & Clinics

Academic Research Institutes

Others

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Abbott

bioMérieux

Danaher

F. Hoffmann-La Roche Ltd

Siemens Healthineers AG

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Infectious Disease Molecular Diagnostics Market Segmentation

By Product & Service

Reagents

Kits

Consumables

Instruments

Software & Services

 

By Type of Testing

Laboratory Testing

PoC Testing

 

By Technology

Immunodiagnostics

Polymerase Chain Reaction

Clinical Microbiology

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-generation Sequencing

DNA Microarray

Others

 

By Disease Type

Hepatitis

-Hepatitis B

-Hepatitis C

-Others

HIV

Hospital-acquired Infections

Mosquito-borne Diseases

HPV

Chlamydia trachomatis

Neisseria gonorrhea

Tuberculosis

Influenza

Syphilis

Others

 

By Sample Type

Blood, Serum, and Plasma

Urine

Others

 

By End-User

Diagnostic Laboratories

Hospitals & Clinics

Academic Research Institutes

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)